These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29913477)

  • 1. In brief: Another insulin lispro (Admelog) for diabetes.
    Med Lett Drugs Ther; 2018 Jun; 60(1549):e109. PubMed ID: 29913477
    [No Abstract]   [Full Text] [Related]  

  • 2. Lyumjev - a new insulin lispro for diabetes.
    Med Lett Drugs Ther; 2020 Oct; 62(1609):162-163. PubMed ID: 33429408
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine-SORELLA 1 Study.
    Garg SK; Wernicke-Panten K; Rojeski M; Pierre S; Kirchhein Y; Jedynasty K
    Diabetes Technol Ther; 2017 Sep; 19(9):516-526. PubMed ID: 28722480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar pharmacokinetics and pharmacodynamics of rapid-acting insulin lispro products SAR342434 and US- and EU-approved Humalog in subjects with type 1 diabetes.
    Kapitza C; Nowotny I; Lehmann A; Bergmann K; Rotthaeuser B; Nosek L; Becker RHA
    Diabetes Obes Metab; 2017 May; 19(5):622-627. PubMed ID: 27987252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In brief: Semglee - insulin glargine interchangeable with Lantus.
    Med Lett Drugs Ther; 2021 Oct; 63(1634):159-160. PubMed ID: 34550958
    [No Abstract]   [Full Text] [Related]  

  • 6. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U-200 Humalog Insulin Now Available in United States.
    Chabanuk AJ
    Home Healthc Now; 2016 Feb; 34(2):102. PubMed ID: 26835809
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes.
    Home P; Derwahl KM; Ziemen M; Wernicke-Panten K; Pierre S; Kirchhein Y; Garg SK
    Diabetes Technol Ther; 2018 Feb; 20(2):160-170. PubMed ID: 29355435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer insulin analogs: advances in basal insulin replacement.
    Zinman B
    Diabetes Obes Metab; 2013 Mar; 15 Suppl 1():6-10. PubMed ID: 23448197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can insulin humalog be given during pregnancy?].
    Scherbaum WA
    Dtsch Med Wochenschr; 2003 May; 128(21):1190. PubMed ID: 12761695
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.
    Kaiserman K; Rodriguez H; Stephenson A; Wolka L; Fahrbach JL
    Endocr Pract; 2012; 18(3):418-24. PubMed ID: 22297055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of GP40021 insulin lispro biphasic compared with Humalog Mix 25 in Type 2 diabetes mellitus patients.
    Mayorov AY; Mosikian AA; Alpenidze DN; Makarenko IE; Orlova VL; Lunev IS; Verbovaya MV; Zinnatulina BR; Khokhlov AL; Drai RV
    J Comp Eff Res; 2021 Jan; 10(1):55-66. PubMed ID: 33355484
    [No Abstract]   [Full Text] [Related]  

  • 13. Updating the insulin lispro file.
    Grossman LD
    CMAJ; 1998 May; 158(9):1132-3. PubMed ID: 9597962
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials.
    Sun D; Zhang X; Hou XX
    Diabetes Technol Ther; 2018 Sep; 20(9):622-627. PubMed ID: 30095984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
    Renner R; Pfützner A; Trautmann M; Harzer O; Sauter K; Landgraf R
    Diabetes Care; 1999 May; 22(5):784-8. PubMed ID: 10332682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Vignati L; Anderson JH; Iversen PW
    Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical use.
    Nobels FR; Hermans MP; De Leeuw I
    Acta Clin Belg; 1999 Oct; 54(5):246-54. PubMed ID: 10555382
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
    Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J
    Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
    Comulada AL; Renard E; Nakano M; Rais N; Mao X; Webb DM; Milicevic Z
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S17-25. PubMed ID: 19772445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid-acting insulin analogues: when randomized clinical trial results do not help.
    Home PD
    Diabet Med; 2000 Sep; 17 Suppl 2():6-8. PubMed ID: 11048825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.